Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma. Waguespack SG, Drilon A, Lin JJ, Brose MS, et al. Eur J Endocrinol 2022 Mar 1. pii: EJE-21-1259. doi: 10.1530/EJE-21-1259.

Read + Share

Amedeo Smart

Independent Medical Education

Waguespack SG, Drilon A, Lin JJ, Brose MS, et al. Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma. Eur J Endocrinol 2022 Mar 1. pii: EJE-21-1259. doi: 10.1530/EJE-21-1259.
PMID: 35333737